FDA will meet this Thursday to review the Emergency Authorization request from Pfizer-BioNTech for COVID -19
On December 10, 2020, FDA will meet in open session to discuss EUA of the PfizerBioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older.
If approved the vaccine will be the first approved in the United States.
The meeting can be viewed on this page this Thursday at 12pm est.